In invasive breast cancer, protein expression of BCL-6 was observed to be associated with cyclin D1 and hypoxia-inducible factor-1-alpha (HIF-1-alpha), first suggesting that BCL-6 oncogene activation plays a role in cancers other than lymphomas [26]. The gene discussed is HIF1A; the disease is cancer.